NutraMax Products Inc.

Jim McGrath is the executive vice president of regulatory affairs and product development for PBM Pharmaceuticals, where he oversees the development and U.S. Food and Drug Administration approval of innovative pharmaceutical and nutritional products. Before joining PBM, Mr. McGrath held several key management positions in the areas of product development, technical services, quality assurance, and regulatory affairs. He has more than 35 years of experience in the pharmaceutical industry, working for companies such as Wyeth, Rugby-Darby, Circa Pharmaceutical, and NutraMax Products. Mr. McGrath attended the Wharton executive program at the University of Pennsylvania and is a graduate of New York University, where he earned a BS in chemical engineering.

Mr. Korman is Chairman of the Board and has served in this capacity since March 8, 2004. He has served as a director since October 19, 1993. Mr. Korman has been Chairman of the Board of Trustees of Philadelphia Health Care Trust, a private healthcare foundation, since December 1995. Mr. Korman is also a director of The New America High Income Fund, Inc. (NYSE:HYB) (financial services), Medical Nutrition USA, Inc. (OTC:MDNU.OB) (develops and distributes nutritional products) and NutraMax Products, Inc. (OTC:NUTP) (consumer health care products). He was formerly President, Chief Executive Officer and Director of MEDIQ Incorporated (OTC:MDDQP) (health care services) from 1977 to 1995. Mr. Korman served as a trustee of Kramont Realty Trust (NYSE:KRT) (real estate investment trust) from June 2000 until its merger in April 2005 and of The Pep Boys, Inc. (NYSE:PBY) and also served as The Pep Boys, Inc.'s Chairman of the Board from May 28, 2003 until his retirement from such board in September 2004. Mr. Korman was previously a director of Omega Worldwide, Inc.